CLINICAL_TRIALS
trial_result
· 2015-11-02
Clinical Trial Update: Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP (Antabloc Supplementation Autoimmune Prevention) [Phase 2]
Summary
Clinical trial update noting completion of a Phase 2 study evaluating the dietary supplement Anatabloc for autoimmune thyroiditis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rock Creek Pharmaceuticals, Inc. | Conditions: Thyroiditis, Autoimmune | Phase 2 | Status: COMPLETED